The largest database of trusted experimental protocols

2 protocols using sting inhibitor h151

1

Immune Response Pathway Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T and U87 cells were maintained in DMEM (Gibco) supplemented with 10% foetal bovine serum (FBS, LabTech) and 100 U/ml penicillin plus 100 μg/ml streptomycin (Pen/Strep; Gibco). THP‐1 cells were maintained in RPMI (Gibco) supplemented with 10% FBS and Pen/Strep. THP‐1‐IFIT‐1 cells that had been modified to express Gaussia luciferase under the control of the IFIT‐1 promoter were described previously (Mankan et al, 2014). THP‐1 Dual Control and cGAS−/− cells were obtained from Invivogen. Lopinavir (LPV), darunavir (DRV), nevirapine (NVP) and raltegravir were obtained from AIDS reagents. STING inhibitor H151 was obtained from Invivogen. JAK inhibitor ruxolitinib was obtained from CELL guidance systems. PF‐74 was obtained from Sigma. Lipopolysaccharide, IFNβ and poly I:C were obtained from PeproTech. Sendai virus was obtained from Charles River Laboratories. Herring testis DNA was obtained from Sigma. cGAMP was obtained from Invivogen. Anti‐IFNα/β receptor and control IgG2A antibodies were obtained from PBL Interferon Source and R&D systems, respectively. For stimulation of cells by transfection, transfection mixes were prepared using lipofectamine 2000 according to the manufacturer's instructions (Invitrogen).
+ Open protocol
+ Expand
2

Cell Culture and Stimulation Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T, FRhK and U87 cells were maintained in DMEM (Gibco) supplemented with 10% foetal bovine serum (FBS, Labtech) and 100 U/ml penicillin plus 100 µg/ml streptomycin (Pen/Strep; Gibco). THP-1 cells were maintained in RPMI (Gibco) supplemented with 10% FBS and Pen/Strep. THP-1-IFIT-1 cells that had been modified to express Gaussia luciferase under the control of the IFIT-1 promoter [33 (link)] and versions lacking MAVS or STING [34 ] were described previously. THP-1 cells stably depleted for SAMHD1 were also previously described [26 (link)]. THP-1 Dual Control and cGAS-/- cells were obtained from Invivogen. Nevirapine and raltegravir were obtained from AIDS reagents. STING inhibitor H151 and cGAS inhibitor RU.521 were obtained from Invivogen. JAK inhibitor ruxolitinib was obtained from CELL guidance systems. Lipopolysaccharide and IFNβ were obtained from Peprotech. Herring-testis DNA was obtained from Sigma. cGAMP and poly I: C were obtained from Invivogen. For stimulation of cells by transfection, transfection mixes were prepared using lipofectamine 2000 according to the manufacturer’s instructions (Invitrogen).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!